Table of Contents

2019-2024 Global Deferiprone Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Deferiprone Consumption 2014-2024
  • 2.1.2 Deferiprone Consumption CAGR by Region
• 2.2 Deferiprone Segment by Type
  • 2.2.1 Nerve Conduit
  • 2.2.2 Nerve Wrap
  • 2.2.3 Nerve Graft
• 2.3 Deferiprone Consumption by Type
  • 2.3.1 Global Deferiprone Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Deferiprone Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Deferiprone Sale Price by Type (2014-2019)
• 2.4 Deferiprone Segment by Application
  • 2.4.1 Direct Nerve Repair/Neurorrhaphy
  • 2.4.2 Nerve Graft
• 2.5 Deferiprone Consumption by Application
  • 2.5.1 Global Deferiprone Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Deferiprone Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Deferiprone Sale Price by Application (2014-2019)

3 Global Deferiprone by Players

• 3.1 Global Deferiprone Sales Market Share by Players
  • 3.1.1 Global Deferiprone Sales by Players (2017-2019)
  • 3.1.2 Global Deferiprone Sales Market Share by Players (2017-2019)
• 3.2 Global Deferiprone Revenue Market Share by Players
  • 3.2.1 Global Deferiprone Revenue by Players (2017-2019)
  • 3.2.2 Global Deferiprone Revenue Market Share by Players (2017-2019)
• 3.3 Global Deferiprone Sale Price by Players
• 3.4 Global Deferiprone Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Deferiprone Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Deferiprone Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Deferiprone by Regions

• 4.1 Deferiprone by Regions
  • 4.1.1 Global Deferiprone Consumption by Regions
  • 4.1.2 Global Deferiprone Value by Regions
• 4.2 Americas Deferiprone Consumption Growth
• 4.3 APAC Deferiprone Consumption Growth
• 4.4 Europe Deferiprone Consumption Growth
• 4.5 Middle East & Africa Deferiprone Consumption Growth

5 Americas

• 5.1 Americas Deferiprone Consumption by Countries
  • 5.1.1 Americas Deferiprone Consumption by Countries (2014-2019)
  • 5.1.2 Americas Deferiprone Value by Countries (2014-2019)
• 5.2 Americas Deferiprone Consumption by Type
• 5.3 Americas Deferiprone Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Deferiprone Consumption by Countries
  • 6.1.1 APAC Deferiprone Consumption by Countries (2014-2019)
  • 6.1.2 APAC Deferiprone Value by Countries (2014-2019)
• 6.2 APAC Deferiprone Consumption by Type
• 6.3 APAC Deferiprone Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Deferiprone by Countries
  • 7.1.1 Europe Deferiprone Consumption by Countries (2014-2019)
  • 7.1.2 Europe Deferiprone Value by Countries (2014-2019)
• 7.2 Europe Deferiprone Consumption by Type
• 7.3 Europe Deferiprone Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Deferiprone by Countries
  • 8.1.1 Middle East & Africa Deferiprone Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Deferiprone Value by Countries (2014-2019)
• 8.2 Middle East & Africa Deferiprone Consumption by Type
• 8.3 Middle East & Africa Deferiprone Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Deferiprone Distributors
• 10.3 Deferiprone Customer

11 Global Deferiprone Market Forecast

• 11.1 Global Deferiprone Consumption Forecast (2019-2024)
• 11.2 Global Deferiprone Forecast by Regions
  • 11.2.1 Global Deferiprone Forecast by Regions (2019-2024)
  • 11.2.2 Global Deferiprone Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Deferiprone Forecast by Type
• 11.8 Global Deferiprone Forecast by Application

12 Key Players Analysis

• 12.1 Stryker
  • 12.1.1 Company Details
  • 12.1.2 Deferiprone Product Offered
  • 12.1.3 Stryker Deferiprone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Stryker News
• 12.2 Axogen
  • 12.2.1 Company Details
  • 12.2.2 Deferiprone Product Offered
  • 12.2.3 Axogen Deferiprone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Axogen News
• 12.3 Integra
  • 12.3.1 Company Details
  • 12.3.2 Deferiprone Product Offered
  • 12.3.3 Integra Deferiprone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Integra News
• 12.4 Polyganics
  • 12.4.1 Company Details
  • 12.4.2 Deferiprone Product Offered
  • 12.4.3 Polyganics Deferiprone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Polyganics News

...

13 Research Findings and Conclusion

Nerve damages can be caused by either blunt trauma, such as an impact from a fall or from traction injuries from motor vehicle accidents, or sharp trauma, such as direct cuts from a knife. Injury to a nerve can stop signals to and from the brain. Surgical nerve repair involves the exploration of the injured nerve and the removal of injured tissue from the nerve endings. Nerve repair and regeneration product are used through surgical interventions to restore normal function in nerves.
The major players in the global nerve repair and regeneration market are Stryker, Axogen, Integra, Polyganics and etc. and the top three players accounts about 94% of the total revenue in 2016.
On the basis of geography, the global nerve repair and regeneration market can be segmented into USA, Europe and Rest of the World. Due to a large patient population and increase in the incidence of nerve injuries, North America is deemed to be the key contributor towards the growth of the market.
Based on product, the nerve repair and regeneration market can be classified into Nerve Conduit (volume market share 60% in 2016), Nerve Wrap (volume market share 39% in 2016), Nerve Graft (volume market share 2% in 2016) and others.

According to this study, over the next five years the Deferiprone market will register a 24.6% CAGR in terms of revenue, the global market size will reach US$ 490 million by 2024, from US$ 130 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Deferiprone business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Deferiprone market by product type, application, key manufacturers and key regions and countries.

This study considers the Deferiprone value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Nerve Conduit
Nerve Wrap
Nerve Graft
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Direct Nerve Repair/Neurorrhaphy
Nerve Graft

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Stryker
Axogen
Integra
Polyganics
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Deferiprone consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Deferiprone market by identifying its various subsegments.
Focuses on the key global Deferiprone manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Deferiprone with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Deferiprone submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.